FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2738456700> ?p ?o ?g. }

• W2738456700 abstract "Background The Japan Society of Hepatology guidelines indicate that hepatitis C virus (HCV) protease inhibitor combination therapy with simeprevir (SMV), pegylated‐interferon (Peg‐IFN), and ribavirin (RBV) is a therapeutic option for patients who fail to respond to a direct direct‐acting antiviral‐containing regimen. However, treatment outcomes have room for improvement. Fluvastatin (FLV) add‐on treatment in Peg‐IFN and RBV combination therapy for HCV‐infected patients significantly improved the sustained virologic response (SVR), but the add‐on effect of FLV on SMV combination therapy is not well understood. Methods This was a prospective, randomized, multicenter study in which a total of 61 HCV genotype 1b‐infected patients were recruited and 60 eligible patients were randomly allocated to two groups that received 12 weeks of SMV/Peg‐IFN/RBV followed by 12 weeks of Peg‐IFN/RBV with or without 24 weeks of FLV. The SVR rate and adverse events were compared between the two groups. Results Thirty‐one patients were allocated to the FLV add‐on group and 29 patients were allocated to the control group. Baseline clinical factors, including median age, baseline platelet count, alanine aminotransferase level, HCV RNA titer, Fibrosis‐4 index, and rate of IL28B minor genotype, were all similar between the two groups. The rapid virologic response, end‐of‐treatment response rates, SVR rates at 24 weeks after treatment, and safety profiles were also similar between the two groups. Conclusions This prospective, randomized, multicenter study indicated that FLV had no add‐on effect when given with SMV/Peg‐IFN/RBV combination therapy for genotype 1b HCV‐infected patients." @default.
• W2738456700 created "2017-07-31" @default.
• W2738456700 creator A5003644676 @default.
• W2738456700 creator A5016138007 @default.
• W2738456700 creator A5020231124 @default.
• W2738456700 creator A5024713150 @default.
• W2738456700 creator A5025757104 @default.
• W2738456700 creator A5029167813 @default.
• W2738456700 creator A5031216911 @default.
• W2738456700 creator A5046602598 @default.
• W2738456700 creator A5047266289 @default.
• W2738456700 creator A5048212539 @default.
• W2738456700 creator A5051255682 @default.
• W2738456700 creator A5053029290 @default.
• W2738456700 creator A5054771915 @default.
• W2738456700 creator A5057000189 @default.
• W2738456700 creator A5060686264 @default.
• W2738456700 creator A5061376740 @default.
• W2738456700 creator A5070540147 @default.
• W2738456700 creator A5070753522 @default.
• W2738456700 creator A5075045544 @default.
• W2738456700 creator A5081579462 @default.
• W2738456700 creator A5087097830 @default.
• W2738456700 creator A5088413538 @default.
• W2738456700 creator A5039738293 @default.
• W2738456700 date "2017-08-10" @default.
• W2738456700 modified "2023-10-16" @default.
• W2738456700 title "Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study" @default.
• W2738456700 cites W1551301313 @default.
• W2738456700 cites W1886304235 @default.
• W2738456700 cites W1968000667 @default.
• W2738456700 cites W1978892007 @default.
• W2738456700 cites W1987584200 @default.
• W2738456700 cites W2005895808 @default.
• W2738456700 cites W2022040029 @default.
• W2738456700 cites W2032624194 @default.
• W2738456700 cites W2040463244 @default.
• W2738456700 cites W2057318017 @default.
• W2738456700 cites W2088337379 @default.
• W2738456700 cites W2089691623 @default.
• W2738456700 cites W2093074785 @default.
• W2738456700 cites W2101598010 @default.
• W2738456700 cites W2103382758 @default.
• W2738456700 cites W2111925219 @default.
• W2738456700 cites W2118606767 @default.
• W2738456700 cites W2121960517 @default.
• W2738456700 cites W2131992264 @default.
• W2738456700 cites W2145567849 @default.
• W2738456700 cites W2155820299 @default.
• W2738456700 cites W2234102010 @default.
• W2738456700 cites W2264049562 @default.
• W2738456700 cites W2274200112 @default.
• W2738456700 cites W2417045008 @default.
• W2738456700 cites W2523466376 @default.
• W2738456700 cites W2524545167 @default.
• W2738456700 cites W2566350519 @default.
• W2738456700 doi "https://doi.org/10.1111/hepr.12938" @default.
• W2738456700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28722780" @default.
• W2738456700 hasPublicationYear "2017" @default.
• W2738456700 type Work @default.
• W2738456700 sameAs 2738456700 @default.
• W2738456700 citedByCount "1" @default.
• W2738456700 countsByYear W27384567002020 @default.
• W2738456700 crossrefType "journal-article" @default.
• W2738456700 hasAuthorship W2738456700A5003644676 @default.
• W2738456700 hasAuthorship W2738456700A5016138007 @default.
• W2738456700 hasAuthorship W2738456700A5020231124 @default.
• W2738456700 hasAuthorship W2738456700A5024713150 @default.
• W2738456700 hasAuthorship W2738456700A5025757104 @default.
• W2738456700 hasAuthorship W2738456700A5029167813 @default.
• W2738456700 hasAuthorship W2738456700A5031216911 @default.
• W2738456700 hasAuthorship W2738456700A5039738293 @default.
• W2738456700 hasAuthorship W2738456700A5046602598 @default.
• W2738456700 hasAuthorship W2738456700A5047266289 @default.
• W2738456700 hasAuthorship W2738456700A5048212539 @default.
• W2738456700 hasAuthorship W2738456700A5051255682 @default.
• W2738456700 hasAuthorship W2738456700A5053029290 @default.
• W2738456700 hasAuthorship W2738456700A5054771915 @default.
• W2738456700 hasAuthorship W2738456700A5057000189 @default.
• W2738456700 hasAuthorship W2738456700A5060686264 @default.
• W2738456700 hasAuthorship W2738456700A5061376740 @default.
• W2738456700 hasAuthorship W2738456700A5070540147 @default.
• W2738456700 hasAuthorship W2738456700A5070753522 @default.
• W2738456700 hasAuthorship W2738456700A5075045544 @default.
• W2738456700 hasAuthorship W2738456700A5081579462 @default.
• W2738456700 hasAuthorship W2738456700A5087097830 @default.
• W2738456700 hasAuthorship W2738456700A5088413538 @default.
• W2738456700 hasBestOaLocation W27384567001 @default.
• W2738456700 hasConcept C126322002 @default.
• W2738456700 hasConcept C197934379 @default.
• W2738456700 hasConcept C203014093 @default.
• W2738456700 hasConcept C2522874641 @default.
• W2738456700 hasConcept C2776408679 @default.
• W2738456700 hasConcept C2776455275 @default.
• W2738456700 hasConcept C2776461080 @default.
• W2738456700 hasConcept C2776999253 @default.
• W2738456700 hasConcept C2778986448 @default.
• W2738456700 hasConcept C2780040827 @default.
• W2738456700 hasConcept C2781413609 @default.
• W2738456700 hasConcept C41260117 @default.

• next